<DOC>
	<DOCNO>NCT01052103</DOCNO>
	<brief_summary>The purpose study determine whether LY2140023 , add standard-of-care antipsychotic treatment , improve negative symptom .</brief_summary>
	<brief_title>A Study LY2140023 Schizophrenia Patients With Prominent Negative Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Clinical diagnosis schizophrenia Patients must receive monotherapy treatment least 3 month prior study entry one 4 atypical antipsychotic medication ( aripiprazole , olanzapine , risperidone , quetiapine ) Disease symptom must meet certain range assess clinician Patients must evidence prominent negative symptom schizophrenia ( i.e . blunt affect , emotional withdrawal , motor retardation ) Patients must consider reliable , level understanding sufficient perform test examination require protocol , willing perform study procedures Patients must able understand nature study give informed consent Patients actively suicidal Patients pregnant nursing Patients electroconvulsive therapy ( ECT ) within 3 month screen ECT time study Patients uncorrected narrowangle glaucoma , history current seizure disorder , uncontrolled diabetes , certain disease liver , renal insufficiency , uncontrolled thyroid condition serious unstable illness Patients Parkinson 's disease , psychosis relate dementia relate disorder Patients know Human Immunodeficiency Virus positive ( HIV+ ) status</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>